Watch Now

Like so many regulated firms, you may have received findings, observations, a warning letter, or 483 from either an outside audit, registrar, or regulated agency such as the FDA. Don’t panic!

There are steps you can take to mitigate the process and become compliant by addressing each one in a planned and organized manner. This webinar will highlight those steps and take you through the process from planning to implementation.

The Audit Failure & FDA Warning Letter presentation will include:

  • Proper planning
  • Initial responses
  • Selecting the right resources
  • Execution and Implementation of Remediation
  • Maintaining Compliance
  • Validation process and procedures
  • Live Q & A session
Bob Lucchesi
Bob Lucchesi

Vice President of Global Regulatory Compliance, Quality Assurance and Auditing Bob is the Vice President of Global Regulatory Compliance, Quality Assurance, and Auditing at USDM Life Sciences. He has more than 30 years of experience in quality assurance and regulatory compliance in the pharmaceuticals, biotech, medical device, engineering, and nuclear industries.

Want our experts to work on your project?

Take the first step towards creating more value with USDM today.

Connect Now

We use cookies to understand how you use our site and improve your experience. This includes personalizing content and advertising. Learn more.